Figure 5.
Figure 5. Effect of autoantibody adsorption with immobilized GPIIb-IIIa. Biotinylated murine monoclonal anti-GPIIb (2A9), coupled to avidin-Sepharose beads, was incubated with normal platelet lysate to allow GPIIb-IIIa binding. After washing, test plasmas (patient plasmas containing anti-GPIIb/IIIa antibody [ITP-1, ITP-5] and control plasmas [Cont-1, Cont-2]) were incubated with 2 separate aliquots of the immobilized GPIIb-IIIa, followed by centrifugation. Adsorption removed more than 80% of the autoantibody, as demonstrated in binding assays. Unadsorbed and adsorbed (ads) plasmas were tested, and the total numbers of megakaryocytes present after 10 days were determined.

Effect of autoantibody adsorption with immobilized GPIIb-IIIa. Biotinylated murine monoclonal anti-GPIIb (2A9), coupled to avidin-Sepharose beads, was incubated with normal platelet lysate to allow GPIIb-IIIa binding. After washing, test plasmas (patient plasmas containing anti-GPIIb/IIIa antibody [ITP-1, ITP-5] and control plasmas [Cont-1, Cont-2]) were incubated with 2 separate aliquots of the immobilized GPIIb-IIIa, followed by centrifugation. Adsorption removed more than 80% of the autoantibody, as demonstrated in binding assays. Unadsorbed and adsorbed (ads) plasmas were tested, and the total numbers of megakaryocytes present after 10 days were determined.

Close Modal

or Create an Account

Close Modal
Close Modal